Goldman Sachs says Tesla Optimus and robotaxi outlook overshadow Q3 earnings

By Splitfeed EditorialLast updated Oct 13, 2026, 12:50 UTC

Around October 12 and 13, 2026, two overlapping developments drew attention to Tesla's longer-term technology bets. Reports on October 12 indicated that Tesla's Optimus humanoid robot could go on sale in 2027, though no pricing or preorder details have been announced by the company. Separately, a piece published the same day identified six specific developments tied to Tesla's ongoing Optimus data collection push. Then on October 13, Goldman Sachs framed the investment conversation explicitly, arguing that Tesla's robotaxi and Optimus prospects will matter more to investors than the company's third-quarter earnings. Goldman also set out what it described as a performance bar for October, positioning autonomy and humanoid robot milestones as the metrics the market is watching most closely.

The Goldman framing matters because it reflects a broader shift in how major financial institutions are valuing Tesla. If near-term earnings are being discounted in favor of speculative hardware and autonomy timelines, then Tesla is increasingly being priced on promises rather than present revenue, which creates both opportunity and risk. The 2027 sale window for Optimus is still unconfirmed by Tesla itself, and the absence of pricing or preorder mechanisms means the timeline remains soft. What is genuinely in dispute is whether Tesla's data collection efforts and engineering progress justify that forward-looking valuation, or whether the gap between announcement and delivery will continue to widen.

No specific reactions from the Pro-AI, Anti-AI, or Middle Ground camps have been published in the inputs provided. Typically, Pro-AI voices would treat Goldman's framing as validation that transformative robotics and autonomy are approaching commercial reality and deserve premium market attention. Anti-AI commentators would likely argue that grounding investor expectations in unpriced, unannounced products is a pattern that has repeatedly deferred accountability. Middle Ground observers would generally want concrete delivery dates, verified production capacity, and regulatory clarity before accepting the 2027 timeline as meaningful.

The clearest near-term signal to watch is Tesla's Q3 earnings call itself, where management may or may not offer updated guidance on Optimus commercialization timelines. Any announcement of pricing, a preorder window, or a revised production schedule would either substantiate or complicate Goldman's framing considerably.